As a leader in the field of bringing the findings of basic research to clinical application, LA BioMed is involved in conducting many clinical trials. Clinical trials are the method of objectively assessing whether novel therapies are safe and effective in treating disease.

LA BioMed conducts many trials on behalf of pharmaceutical companies and companies that manufacture therapeutic devices, but its investigators also sponsor and conduct trials based on their own research efforts. Some of our current clinical trials are listed below.

For a listing of all clinical trials that LA BioMed is involved with, please go to the Clinicaltrials.gov website, which lists all clinical trials across the United States. If you are interested in our clinical trials, searching this database with terms like “LA BioMed” or “Harbor-UCLA” will show which trials are being conducted at our site. If you are interested in a particular disease, searching by that disease name will show trials at all sites across the U.S. To find out if LA BioMed is involved in testing treatments for a particular condition, use the search format “disease AND LA BioMed”.

Spotlight on LA BioMed Clinical Trials

Title: A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection (PRIMO)

Brief Summary: This clinical trial tests the hypotheses that 1) body decolonization of patients with recurrent community-associated (CA) MRSA infections and their household members and 2) environmental decolonization of the patients' households will significantly reduce the likelihood of recurrent CA-MRSA infection.(more)

Title: The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study

Brief Summary: The purpose of this study is to determine if the addition of the medication, deferasirox, to standard antifungal therapy for the infection, mucormycosis, is safe and effective (more)

Title: L-Glutamine Therapy for Sickle Cell Anemia

Brief Summary: To primary purpose is to evaluate the effect of L-glutamine therapy on exercise endurance and breath by breath exercise response of sickle cell anemia patients.
The secondary purpose is to assess the effect of L-glutamine on pain; energy and appetite levels; narcotics usage; and hospital and emergency room visits for sickle cell pain. (more)